Pharma Journalist -

Thermo Fisher Scientific Inc. and PPD, Inc. announced that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share…
Read More...

Alligator Bioscience announced that it has entered into a joint research collaboration with MacroGenics, Inc. a biopharmaceutical company focused on developing and commercializing…
Read More...

INOVIO a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, and cancer, announced the…
Read More...

Arch Biopartners Inc. announced it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain (“Telara”) to clinically develop and market cilastatin, a…
Read More...

SciNeuro Pharmaceuticals, an innovative biopharmaceutical company focused on delivering transformative therapies to patients with neurological diseases, has entered into an exclusive…
Read More...

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a partnership with Pure…
Read More...

AbCellera and Empirico Inc. announced that they have entered into a strategic multi-target discovery collaboration. Through each company’s proprietary technologies, the multi-target…
Read More...

Tango Therapeutics, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, and BCTG Acquisition Corp. a special purpose…
Read More...

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Trodelvy (sacituzumab govitecan-hziy) for use in adult patients with…
Read More...

Spark Therapeutics, a member of the Roche Group and a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced a…
Read More...